A Double-Blind, Placebo-Controlled Study Demonstrates Sodium Oxybate Is Effective for the Treatment of Excessive Daytime Sleepiness in Narcolepsy
2005; American Academy of Sleep Medicine; Volume: 01; Issue: 04 Linguagem: Inglês
10.5664/jcsm.26368
ISSN1550-9397
AutoresThe Xyrem reg, International Study Group,
Tópico(s)Sleep and Wakefulness Research
ResumoFree AccessA Double-Blind, Placebo-Controlled Study Demonstrates Sodium Oxybate Is Effective for the Treatment of Excessive Daytime Sleepiness in Narcolepsy The Xyrem®, International Study Group The Xyrem® Orphan Medical, Inc., A Subsidiary of Jazz Pharmaceuticals, Palo Alto, CA , International Study Group Orphan Medical, Inc., A Subsidiary of Jazz Pharmaceuticals, Palo Alto, CA Published Online:October 15, 2005https://doi.org/10.5664/jcsm.26368Cited by:99SectionsPDF ShareShare onFacebookTwitterLinkedInRedditEmail ToolsAdd to favoritesDownload CitationsTrack Citations About Previous article Next article FiguresReferencesRelatedDetailsCited byDisrupted nighttime sleep and sleep instability in narcolepsyMaski K, Mignot E, Plazzi G and Dauvilliers Y Journal of Clinical Sleep Medicine, Vol. 18, No. 1, (289-304), Online publication date: 1-Jan-2022.Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessmentMaski K, Trotti L, Kotagal S, Robert Auger R, Swick T, Rowley J, Hashmi S and Watson N Journal of Clinical Sleep Medicine, Vol. 17, No. 9, (1895-1945), Online publication date: 1-Sep-2021. Narkolepsie im Erwachsenenalter: Definition, Ätiologie und BehandlungMalter M, Neuneier J, Triller A and Kallweit U Fortschritte der Neurologie · Psychiatrie, 10.1055/a-1244-2612, Vol. 89, No. 03, (103-113), Online publication date: 1-Mar-2021. Bioulac S and Franco P Stimulants Pediatric Sleep Medicine, 10.1007/978-3-030-65574-7_22, (291-298), . Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexyBogan R, Thorpy M, Dauvilliers Y, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Tang L, Skobieranda F and Šonka K Sleep, 10.1093/sleep/zsaa206, Incidence and duration of common, early-onset adverse events occurring during 2 randomized, placebo-controlled, phase 3 studies of sodium oxybate in participants with narcolepsyHusain A, Bujanover S, Ryan R, Scheckner B, Black J and Profant J Journal of Clinical Sleep Medicine, Vol. 16, No. 9, (1469-1474), Online publication date: 15-Sep-2020. The Sodium in Sodium Oxybate: Is There Cause for Concern?Avidan A and Kushida C Sleep Medicine, 10.1016/j.sleep.2020.09.017, , Online publication date: 1-Sep-2020. Population and Noncompartmental Pharmacokinetics of Sodium Oxybate Support Weight‐Based Dosing in Children and Adolescents With Narcolepsy With CataplexyChen C, Rosen C, Ruoff C, Boyce L, Parvataneni R, Zomorodi K, Brantley S, Sale M and Plazzi G Clinical and Translational Science, 10.1111/cts.12780 Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implicationsThorpy M and Bogan R Sleep Medicine, 10.1016/j.sleep.2019.09.001, Vol. 68, , (97-109), Online publication date: 1-Apr-2020. Gamma-hydroxybutyrate (GHB) for narcolepsy in adults: an updated systematic review and meta-analysisXu X, Wei Y, Liu Y and Li Z Sleep Medicine, 10.1016/j.sleep.2019.06.017, Vol. 64, , (62-70), Online publication date: 1-Dec-2019. Treatment of Excessive Daytime Sleepiness in Patients with NarcolepsyPérez-Carbonell L Current Treatment Options in Neurology, 10.1007/s11940-019-0595-9, Vol. 21, No. 11, Online publication date: 1-Nov-2019. An evaluation of sodium oxybate as a treatment option for narcolepsyAbad V Expert Opinion on Pharmacotherapy, 10.1080/14656566.2019.1617273, Vol. 20, No. 10, (1189-1199), Online publication date: 3-Jul-2019. Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapySzabo S, Thorpy M, Mayer G, Peever J and Kilduff T Sleep Medicine Reviews, 10.1016/j.smrv.2018.09.006, Vol. 43, , (23-36), Online publication date: 1-Feb-2019. Multiple treatment comparison in narcolepsy: a network meta-analysisLehert P and Falissard B Sleep, 10.1093/sleep/zsy185, Vol. 41, No. 12, Online publication date: 1-Dec-2018. Neural network analysis of sleep stages enables efficient diagnosis of narcolepsyStephansen J, Olesen A, Olsen M, Ambati A, Leary E, Moore H, Carrillo O, Lin L, Han F, Yan H, Sun Y, Dauvilliers Y, Scholz S, Barateau L, Hogl B, Stefani A, Hong S, Kim T, Pizza F, Plazzi G, Vandi S, Antelmi E, Perrin D, Kuna S, Schweitzer P, Kushida C, Peppard P, Sorensen H, Jennum P and Mignot E Nature Communications, 10.1038/s41467-018-07229-3, Vol. 9, No. 1, Online publication date: 1-Dec-2018. Sodium Oxybate–Associated Confusion in the Older AdultDoshi V, Cross C and Muppavarapu K American Journal of Therapeutics, 10.1097/MJT.0000000000000625, Vol. 25, No. 6, (e678), Online publication date: 1-Nov-2018. Long-term compliance, safety, and tolerability of sodium oxybate treatment in patients with narcolepsy type 1: a postauthorization, noninterventional surveillance studyMayer G, Plazzi G, Iranzo Á, Ortega-Albás J, Quinnell T, Pesch H, Serralheiro P, Schlit A, Wuiame D and Bentz J Sleep, 10.1093/sleep/zsy128, Vol. 41, No. 9, Online publication date: 1-Sep-2018. Criteria for gauging response to sodium oxybate for narcolepsySteffen A, Lai C and Weaver T Journal of Sleep Research, 10.1111/jsr.12628, Vol. 27, No. 4, (e12628), Online publication date: 1-Aug-2018. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigationPlazzi G, Ruoff C, Lecendreux M, Dauvilliers Y, Rosen C, Black J, Parvataneni R, Guinta D, Wang Y and Mignot E The Lancet Child & Adolescent Health, 10.1016/S2352-4642(18)30133-0, Vol. 2, No. 7, (483-494), Online publication date: 1-Jul-2018. The cost-utility of sodium oxybate as narcolepsy treatmentBolin K, Berling P, Wasling P, Meinild H, Kjellberg J and Jennum P Acta Neurologica Scandinavica, 10.1111/ane.12794, Vol. 136, No. 6, (715-720), Online publication date: 1-Dec-2017. Effect of sodium oxybate, modafinil, and their combination on disrupted nighttime sleep in narcolepsyDauvilliers Y, Roth T, Guinta D, Alvarez-Horine S, Dynin E and Black J Sleep Medicine, 10.1016/j.sleep.2017.07.030, Vol. 40, , (53-57), Online publication date: 1-Dec-2017. Correlation of Changes in Patient-Reported Quality of Life With Physician-Rated Global Impression of Change in Patients With Narcolepsy Participating in a Clinical Trial of Sodium Oxybate: A Post Hoc AnalysisBogan R, Black J, Swick T, Mamelak M, Kovacevic-Ristanovic R, Villa K, Mori F and Montplaisir J Neurology and Therapy, 10.1007/s40120-017-0076-6, Vol. 6, No. 2, (237-245), Online publication date: 1-Dec-2017. Correlation between the Epworth Sleepiness Scale and the Maintenance of Wakefulness Test in patients with narcolepsy participating in two clinical trials of sodium oxybateErman M, Emsellem H, Black J, Mori F and Mayer G Sleep Medicine, 10.1016/j.sleep.2017.07.015, Vol. 38, , (92-95), Online publication date: 1-Oct-2017. Sleepiness in NarcolepsyZhang J and Han F Sleep Medicine Clinics, 10.1016/j.jsmc.2017.03.008, Vol. 12, No. 3, (323-330), Online publication date: 1-Sep-2017. Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsyRoth T, Dauvilliers Y, Guinta D, Alvarez-Horine S, Dynin E and Black J Journal of Sleep Research, 10.1111/jsr.12468, Vol. 26, No. 4, (407-414), Online publication date: 1-Aug-2017. Pharmacological management of narcolepsy with and without cataplexyKallweit U and Bassetti C Expert Opinion on Pharmacotherapy, 10.1080/14656566.2017.1323877, Vol. 18, No. 8, (809-817), Online publication date: 24-May-2017. Kimbrough D and Braley T Sleep and Multiple Sclerosis Sleep and Neurologic Disease, 10.1016/B978-0-12-804074-4.00009-1, (167-182), . Evaluation of Quality of Life in Patients With Narcolepsy Treated With Sodium Oxybate: Use of the 36-Item Short-Form Health Survey in a Clinical TrialBogan R, Swick T, Mamelak M, Kovacevic-Ristanovic R, Lai C, Black J, Villa K and Montplaisir J Neurology and Therapy, 10.1007/s40120-016-0053-5, Vol. 5, No. 2, (203-213), Online publication date: 1-Dec-2016. The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humansBosch O and Seifritz E Brain Research Bulletin, 10.1016/j.brainresbull.2016.02.002, Vol. 126, , (47-60), Online publication date: 1-Sep-2016. Sleep-stage sequencing of sleep-onset REM periods in MSLT predicts treatment response in patients with narcolepsyDrakatos P, Patel K, Thakrar C, Williams A, Kent B and Leschziner G Journal of Sleep Research, 10.1111/jsr.12363, Vol. 25, No. 2, (203-210), Online publication date: 1-Apr-2016. Mayer G Sodium Oxybate in the Treatment of Narcolepsy Narcolepsy, 10.1007/978-3-319-23739-8_24, (341-350), . Nishino S and Kotorii N Modes of Action of Drugs Related to Narcolepsy: Pharmacology of Wake-Promoting Compounds and Anticataplectics Narcolepsy, 10.1007/978-3-319-23739-8_22, (307-329), . Nishino S and Kotorii N Overview of Management of Narcolepsy Narcolepsy, 10.1007/978-3-319-23739-8_21, (285-305), . A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosisBraley T and Chervin R Therapeutic Advances in Neurological Disorders, 10.1177/1756285615605698, Vol. 8, No. 6, (294-310), Online publication date: 1-Nov-2015. Time to Response with Sodium Oxybate for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with NarcolepsyBogan R, Roth T, Schwartz J and Miloslavsky M Journal of Clinical Sleep Medicine, Vol. 11, No. 04, (427-432), Online publication date: 15-Apr-2015. A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexyMamelak M, Swick T, Emsellem H, Montplaisir J, Lai C and Black J Sleep Medicine, 10.1016/j.sleep.2014.10.004, Vol. 16, No. 1, (52-58), Online publication date: 1-Jan-2015. Berry R and Wagner M Patients with Daytime Sleepiness and Cataplexy Sleep Medicine Pearls, 10.1016/B978-1-4557-7051-9.00093-0, (508-511), . BaHammam A, Neubauer D and Pandi-Perumal S Sodium Oxybate (Xyrem®): A New and Effective Treatment for Narcolepsy with Cataplexy Drug Treatment of Sleep Disorders, 10.1007/978-3-319-11514-6_11, (231-248), . Broughton R Gamma-Hydroxybutyrate (Sodium Oxybate): From the Initial Synthesis to the Treatment of Narcolepsy–Cataplexy and Beyond Sleep Medicine, 10.1007/978-1-4939-2089-1_63, (557-571), . Sodium oxybate: a guide to its use in narcolepsyLyseng-Williamson K Drugs & Therapy Perspectives, 10.1007/s40267-014-0140-6, Vol. 30, No. 8, (282-289), Online publication date: 1-Aug-2014. Glucose and Fat Metabolism in Narcolepsy and the Effect of Sodium Oxybate: A Hyperinsulinemic-Euglycemic Clamp StudyDonjacour C, Aziz N, Overeem S, Kalsbeek A, Pijl H and Lammers G Sleep, 10.5665/sleep.3592, Vol. 37, No. 4, (795-801), Online publication date: 1-Apr-2014. Billiard M Hypersomnolence: Central Disorders Encyclopedia of Psychopharmacology, 10.1007/978-3-642-27772-6_319-2, (1-8), . Nocturnal Temazepam in the Treatment of NarcolepsyKansagra S, Walter R and Vaughn B Journal of Clinical Sleep Medicine, Vol. 09, No. 05, (499-500), Online publication date: 15-May-2013. Sleep Medicine Pharmacotherapeutics OverviewGulyani S, Salas R and Gamaldo C Chest, 10.1378/chest.12-0561, Vol. 143, No. 1, (242-251), Online publication date: 1-Jan-2013. N Ferri's Clinical Advisor 2013, 10.1016/B978-0-323-08373-7.00023-6, (729-749), . St Louis E and Stephenson C Treatment of Hypersomnia Encyclopedia of Sleep, 10.1016/B978-0-12-378610-4.00245-X, (513-519), . Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): A systematic review and meta-analysis of randomized controlled trialsBoscolo-Berto R, Viel G, Montagnese S, Raduazzo D, Ferrara S and Dauvilliers Y Sleep Medicine Reviews, 10.1016/j.smrv.2011.09.001, Vol. 16, No. 5, (431-443), Online publication date: 1-Oct-2012. Sodium Oxybate for Narcolepsy with Cataplexy: Systematic Review and Meta-AnalysisAlshaikh M, Tricco A, Tashkandi M, Mamdani M, Straus S and BaHammam A Journal of Clinical Sleep Medicine, Vol. 08, No. 04, (451-458), Online publication date: 15-Aug-2012. Sodium oxybate in the treatment of childhood narcolepsy–cataplexy: A retrospective studyMansukhani M and Kotagal S Sleep Medicine, 10.1016/j.sleep.2011.10.032, Vol. 13, No. 6, (606-610), Online publication date: 1-Jun-2012. Pharmacotherapy of Excessive SleepinessRoth T Sleep Medicine Clinics, 10.1016/j.jsmc.2012.03.002, Vol. 7, No. 2, (333-340), Online publication date: 1-Jun-2012. The use of sodium oxybate to treat narcolepsyMayer G Expert Review of Neurotherapeutics, 10.1586/ern.12.42, Vol. 12, No. 5, (519-529), Online publication date: 1-May-2012. Reconsidering GHB: orphan drug or new model antidepressant?Bosch O, Quednow B, Seifritz E and Wetter T Journal of Psychopharmacology, 10.1177/0269881111421975, Vol. 26, No. 5, (618-628), Online publication date: 1-May-2012. Excessive daytime sleepiness and narcolepsy — An approach to investigation and managementMorrison I and Riha R European Journal of Internal Medicine, 10.1016/j.ejim.2011.09.005, Vol. 23, No. 2, (110-117), Online publication date: 1-Mar-2012. Lammers G Narcolepsy Therapy in Sleep Medicine, 10.1016/B978-1-4377-1703-7.10022-2, (289-296), . Berry R Hypersomnias of Central Origin Fundamentals of Sleep Medicine, 10.1016/B978-1-4377-0326-9.00024-5, (451-479), . Chowdhuri S Pharmacology of Sleep Essentials of Sleep Medicine, 10.1007/978-1-60761-735-8_2, (17-54), . Ahmed I and Thorpy M Narcolepsy and Idiopathic Hypersomnia Essentials of Sleep Medicine, 10.1007/978-1-60761-735-8_16, (297-314), . Recent Advances in the Treatment of NarcolepsyHirai N and Nishino S Current Treatment Options in Neurology, 10.1007/s11940-011-0137-6, Vol. 13, No. 5, (437-457), Online publication date: 1-Oct-2011. Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controlsDonjacour C, Aziz N, Roelfsema F, Frölich M, Overeem S, Lammers G and Pijl H American Journal of Physiology-Endocrinology and Metabolism, 10.1152/ajpendo.00623.2010, Vol. 300, No. 6, (E1069-E1075), Online publication date: 1-Jun-2011. Long-Term Follow-Up of Patients With Narcolepsy-Cataplexy Treated With Sodium Oxybate (Xyrem)Alshaikh M, Gacuan D, George S, Sharif M and BaHammam A Clinical Neuropharmacology, 10.1097/WNF.0b013e318203d415, Vol. 34, No. 1, (1-4), Online publication date: 1-Jan-2011. O'Malley M, Gleeson S and Weir I Wake-Promoting Medications Principles and Practice of Sleep Medicine, 10.1016/B978-1-4160-6645-3.00045-1, (527-541), . A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndromeGeorge C, Feldman N, Zheng Y, Steininger T, Grzeschik S, Lai C and Inhaber N Sleep and Breathing, 10.1007/s11325-009-0320-0, Vol. 15, No. 1, (13-20), Online publication date: 1-Jan-2011. Lammers G Treatment of Narcolepsy Narcolepsy, 10.1007/978-1-4419-8390-9_37, (401-409), . Drug-Related Sleep Stage Changes: Functional Significance and Clinical RelevanceRoehrs T and Roth T Sleep Medicine Clinics, 10.1016/j.jsmc.2010.08.002, Vol. 5, No. 4, (559-570), Online publication date: 1-Dec-2010. Billiard M, Dauvilliers Y, Dolenc-Grošelj L, Lammers G, Mayer G and Sonka K Management of Narcolepsy in Adults European Handbook of Neurological Management, 10.1002/9781444328394.ch38, (513-528) Diretrizes brasileiras para o tratamento da narcolepsiaAlóe F, Alves R, Araújo J, Azevedo A, Bacelar A, Bezerra M, Bittencourt L, Bustamante G, Cardoso T, Eckeli A, Fernandes R, Goulart L, Pradella-Hallinan M, Hasan R, Sander H, Pinto Jr. L, Cecília Lopes M, Minhoto G, Moraes W, Moreira G, Pachito D, Pedrazolli M, Poyares D, Prado L, Rizzo G, Nonato Rodrigues R, Roitman I, Ademir Baptista S and Tavares S Revista Brasileira de Psiquiatria, 10.1590/S1516-44462010000300016, Vol. 32, No. 3, (305-314), Online publication date: 1-Sep-2010. Enhancing Slow Wave Sleep with Sodium Oxybate Reduces the Behavioral and Physiological Impact of Sleep LossWalsh J, Hall-Porter J, Griffin K, Dodson E, Forst E, Curry D, Eisenstein R and Schweitzer P Sleep, 10.1093/sleep/33.9.1217, Vol. 33, No. 9, (1217-1225), Online publication date: 1-Sep-2010., Online publication date: 1-Sep-2010. Clinical Features, Diagnosis and Treatment of NarcolepsyAhmed I and Thorpy M Clinics in Chest Medicine, 10.1016/j.ccm.2010.02.014, Vol. 31, No. 2, (371-381), Online publication date: 1-Jun-2010. Armodafinil in the treatment of excessive sleepinessBogan R Expert Opinion on Pharmacotherapy, 10.1517/14656561003705738, Vol. 11, No. 6, (993-1002), Online publication date: 1-Apr-2010. Emerging treatments for narcolepsy and its related disordersNishino S and Okuro M Expert Opinion on Emerging Drugs, 10.1517/14728210903559852, Vol. 15, No. 1, (139-158), Online publication date: 1-Mar-2010. Current Evaluation and Management of Excessive Daytime SleepinessBoulos M and Murray B Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 10.1017/S0317167100009896, Vol. 37, No. 2, (167-176), Online publication date: 1-Mar-2010. Pharmacotherapy of Narcolepsy: Focus on Sodium OxybateKothare S and Kaleyias J Clinical Medicine Insights: Therapeutics, 10.4137/CMT.S1087, Vol. 2, , (CMT.S1087), Online publication date: 1-Jan-2010. Treatment of the Narcoleptiform Sleep Disorder in Chronic Fatigue Syndrome and Fibromyalgia with Sodium OxybateSpitzer A and Broadman M Pain Practice, 10.1111/j.1533-2500.2009.00334.x, Vol. 10, No. 1, (54-59), Online publication date: 1-Jan-2010. Use of sodium oxybate (Xyrem®) in patients with dual diagnosis of narcolepsy and sleep apneaKovačević-Ristanović R and Kuźniar T Sleep Medicine, 10.1016/j.sleep.2009.09.001, Vol. 11, No. 1, (5-6), Online publication date: 1-Jan-2010. Sodium oxybate is an effective and safe treatment for narcolepsyLammers G, Bassetti C, Billiard M, Black J, Broughton R, Dauvilliers Y, Ferini Strambi L, Garcia-Borreguero D, Goswami M, Högl B, Iranzo A, Jennum P, Khatami R, Lecendreux M, Mayer G, Mignot E, Montplaisir J, Nevsimalova S, Peraita-Adrados R, Plazzi G, Scammell T, Silber M, Sonka K, Tafti M and Thorpy M Sleep Medicine, 10.1016/j.sleep.2009.08.003, Vol. 11, No. 1, (105-106), Online publication date: 1-Jan-2010. Mayer G Sodium Oxybate in the Treatment of Narcolepsy Narcolepsy, 10.1007/978-1-4419-0854-4_26, (295-299), . Nishino S Modes of Action of Drugs Related to Narcolepsy: Pharmacology of Wake-Promoting Compounds and Anticataplectics Narcolepsy, 10.1007/978-1-4419-0854-4_24, (267-286), . Nishino S and Kotorii N Overview of Management of Narcolepsy Narcolepsy, 10.1007/978-1-4419-0854-4_23, (251-265), . Shneerson J Narcolepsy and Mental Health Narcolepsy, 10.1007/978-1-4419-0854-4_22, (239-247), . Narcolepsia con y sin cataplejia: una enfermedad rara, limitante e infradiagnosticadaMerino-Andréu M and Martínez-Bermejo A Anales de Pediatría, 10.1016/j.anpedi.2009.07.028, Vol. 71, No. 6, (524-534), Online publication date: 1-Dec-2009. Narcolepsy and depression and the neurobiology of gammahydroxybutyrateMamelak M Progress in Neurobiology, 10.1016/j.pneurobio.2009.07.004, Vol. 89, No. 2, (193-219), Online publication date: 1-Oct-2009. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsyBlack J, Pardi D, Hornfeldt C and Inhaber N Sleep Medicine, 10.1016/j.sleep.2009.05.004, Vol. 10, No. 8, (829-835), Online publication date: 1-Sep-2009. Treatment of narcolepsyDidato G and Nobili L Expert Review of Neurotherapeutics, 10.1586/ern.09.29, Vol. 9, No. 6, (897-910), Online publication date: 1-Jun-2009. Weight loss in narcolepsy patients treated with sodium oxybateHusain A, Ristanovic R and Bogan R Sleep Medicine, 10.1016/j.sleep.2008.05.012, Vol. 10, No. 6, (661-663), Online publication date: 1-Jun-2009. Evidence-Based Recommendations for the Assessment and Management of Sleep Disorders in Older PersonsBloom H, Ahmed I, Alessi C, Ancoli-Israel S, Buysse D, Kryger M, Phillips B, Thorpy M, Vitiello M and Zee P Journal of the American Geriatrics Society, 10.1111/j.1532-5415.2009.02220.x, Vol. 57, No. 5, (761-789) A review of tolerability and abuse liability of γ-hydroxybutyric acid for insomnia in patients with schizophreniaKantrowitz J, Citrome L and Javitt D Clinical Therapeutics, 10.1016/j.clinthera.2009.07.005, Vol. 31, , (1360-1373), Online publication date: 1-Jan-2009. Pediatric narcolepsyPeterson P and Husain A Brain and Development, 10.1016/j.braindev.2008.02.004, Vol. 30, No. 10, (609-623), Online publication date: 1-Nov-2008. Management of narcolepsyBhat A and Solh A Expert Opinion on Pharmacotherapy, 10.1517/14656566.9.10.1721, Vol. 9, No. 10, (1721-1733), Online publication date: 1-Jul-2008. Baclofen and Gamma-Hydroxybutyrate WithdrawalLeTourneau J, Hagg D and Smith S Neurocritical Care, 10.1007/s12028-008-9062-2, Vol. 8, No. 3, (430-433), Online publication date: 1-Jun-2008. Antidepressant drugs for narcolepsyVignatelli L, D'Alessandro R and Candelise L Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003724.pub3 Therapies for narcolepsy with or without cataplexy: evidence-based reviewKeam S and Walker M Current Opinion in Neurology, 10.1097/WCO.0b013e3282f22ad9, Vol. 20, No. 6, (699-703), Online publication date: 1-Dec-2007. VaccinsGerbouin O and Grellet J Actualités Pharmaceutiques Hospitalières, 10.1016/S1769-7344(07)70017-3, Vol. 3, No. 12, (31), Online publication date: 1-Dec-2007. Sodium oxybate: a guide to its use in narcolepsy&NA; Drugs & Therapy Perspectives, 10.2165/00042310-200723080-00001, Vol. 23, No. 8, (1), Online publication date: 1-Aug-2007. NARCOLEPSYThorpy M CONTINUUM: Lifelong Learning in Neurology, 10.1212/01.CON.0000275607.54292.85, Vol. 13, , (101-114), Online publication date: 1-Jun-2007. Therapeutic advances in narcolepsyThorpy M Sleep Medicine, 10.1016/j.sleep.2007.03.004, Vol. 8, No. 4, (427-440), Online publication date: 1-Jun-2007. Sodium OxybateRobinson D and Keating G CNS Drugs, 10.2165/00023210-200721040-00007, Vol. 21, No. 4, (337-354), . EFNS guidelines on management of narcolepsyBilliard M, Bassetti C, Dauvilliers Y, Dolenc-Groselj L, Lammers G, Mayer G, Pollmächer T, Reading P and Sonka K European Journal of Neurology, 10.1111/j.1468-1331.2006.01473.x, Vol. 13, No. 10, (1035-1048), Online publication date: 1-Oct-2006. Sodium oxybate for narcolepsyScharf M Expert Review of Neurotherapeutics, 10.1586/14737175.6.8.1139, Vol. 6, No. 8, (1139-1146), Online publication date: 1-Aug-2006. Cataplexy Associated with NarcolepsyThorpy M CNS Drugs, 10.2165/00023210-200620010-00004, Vol. 20, No. 1, (43-50), . Volume 01 • Issue 04 • October 15, 2005ISSN (print): 1550-9389ISSN (online): 1550-9397Frequency: Monthly Metrics History Published onlineOctober 15, 2005 Information© 2005 American Academy of Sleep MedicinePDF download
Referência(s)